Rawlco Radio Ltd. The Evan Bray Show

The Evan Bray Show - Matthew Kaeberlein - October 15th, 2024

Loading player...
A drug typically prescribed to suppress the immune systems of organ transplant patients is being used by everyday people, now, with the hope of delaying aging and age-related diseases. Dr. Matthew Kaeberlein, CEO of Optispan, an American healthcare technology company, joins Evan to discuss the hype around rapamycin.
15 Oct 2024 10AM English South Africa News Commentary

Other recent episodes

The Evan Bray Show - Dr. Sylvain Charlebois - September 12th, 2025

Canadian counter tariffs have been lifted, while tariffs remain in question by the United States. What does this mean for prices at the grocery store? Dr. Sylvain Charlebois, food distribution and policy professor at Dalhousie University Agri-Food Analytics Lab, joins Evan to discuss the latest in food economics and how…
12 Sep 10AM 13 min
All episodes